Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double Blind Parallel Group Randomised Multiple Dose Study To Evaluate The Pharmacodynamic Response And Safety Of PHA-794428 In Adult Growth Hormone Deficient Patients

NCT00308464 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00308464
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00308464 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double Blind Parallel Group Randomised Multiple Dose Study To Evaluate The Pharmacodynamic Response And Safety Of PHA-794428 In Adult Growth Hormone Deficient Patients
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Terminated
Start date
July 31, 2006
Completion date
December 31, 2007
Enrollment
136
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

growth hormone deficiency